Search

3i Group PLC

Cerrado

SectorÍndices

3,046 -3.7

Resumen

Variación precio

24h

Actual

Mínimo

3037

Máximo

3163

Métricas clave

By Trading Economics

Ingresos

3B

Ventas

1.6B

P/B

Media del Sector

4.986

17.501

BPA

3.09

Rentabilidad por dividendo

2.41

Margen de beneficio

188.169

Empleados

223

EBITDA

3B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+37.11% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

2.41%

8.48%

Fecha Próximo Dividendo

9 ene 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-7.7B

32B

Apertura anterior

3049.7

Cierre anterior

3046

Noticias sobre sentimiento de mercado

By Acuity

74%

26%

24 / 30 Clasificación en Indices

3i Group PLC Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

13 nov 2025, 10:02 UTC

Ganancias
Principales Movimientos del Mercado

3i Group Shares Tumble After Cautious Outlook

13 nov 2025, 07:29 UTC

Ganancias

3i Group: First Div Is Set at 50% of Total Div for FY2025

13 nov 2025, 07:29 UTC

Ganancias

3i Group PLC Declares Dividend of 36.5p

13 nov 2025, 07:28 UTC

Ganancias

3i Group Had Net Debt of GBP772M, Gearing of 3%

13 nov 2025, 07:28 UTC

Ganancias

3i Group Ended Period With Liquidity of GBP1.64B

13 nov 2025, 07:26 UTC

Ganancias

3i Group: Several of Other Large Portfolio Companies Are Showing Good Momentum

13 nov 2025, 07:25 UTC

Ganancias

3i Group: Action Continued to Trade Strongly

13 nov 2025, 07:25 UTC

Ganancias

3i Group Private Equity Business Delivered a Gross Investment Return of GBP3.23B

13 nov 2025, 07:25 UTC

Ganancias

3i Group Total Return GBP3.29B, or 13% on Opening Shareholders' Funds

13 nov 2025, 07:12 UTC

Ganancias

3i Group: Action Generated Net Sales of EUR11.23B in Nine Reporting Periods Ending Sep. 28

13 nov 2025, 07:07 UTC

Ganancias

3i Group Private Equity Business Gross Investment Return GBP3.23B

13 nov 2025, 07:07 UTC

Ganancias

3i Group Had Liquidity of GBP1.64B at Sep. 30

13 nov 2025, 07:07 UTC

Ganancias

3i Group Had Net Debt of GBP772M, Gearing of 3%

13 nov 2025, 07:05 UTC

Ganancias

3i Group Raises Dividend to 36.5p Vs 30.5p

13 nov 2025, 07:03 UTC

Ganancias

3i Group: Transaction Market and Wider Environment Likely to Remain Challenging Into Fiscal 2H

13 nov 2025, 07:03 UTC

Ganancias

3i Group: Remain Cautious in Deployment of Capital Into New Investment, Will Continue to Allocate Selectively

13 nov 2025, 07:02 UTC

Ganancias

3i Group 1H NAV/Shr 2,857p

13 nov 2025, 07:02 UTC

Ganancias

3i Group Total Return GBP3.29B

13 nov 2025, 07:00 UTC

Ganancias

3i 1H EPS GBP3.398

13 nov 2025, 07:00 UTC

Ganancias

3i 1H NAV/Shr GBP28.57

2 sept 2025, 11:16 UTC

Charlas de Mercado

3i Group Seems to Value Investments Conservatively -- Market Talk

2 sept 2025, 06:40 UTC

Adquisiciones, fusiones, absorciones

3i Group: Price is 30% Premium to MAIT's March 31 Valuation

2 sept 2025, 06:39 UTC

Adquisiciones, fusiones, absorciones

3i Group Selling MAIT for GBP143M

2 sept 2025, 06:38 UTC

Adquisiciones, fusiones, absorciones

3i Group: DBAG is a Private Equity Fund Advised by Deutsche Beteiligungs

2 sept 2025, 06:38 UTC

Adquisiciones, fusiones, absorciones

3i Group: MAIT is IT Services Provider for Mid-Market Customers in DACH Region

2 sept 2025, 06:38 UTC

Adquisiciones, fusiones, absorciones

3i Group to Sell MAIT to DBAG

24 jul 2025, 06:09 UTC

Ganancias

3i Group: Focus on Actively Managing Portfolio, Remain Cautious on Pricing for New Investment

24 jul 2025, 06:09 UTC

Ganancias

3i Group: Resilient Performance from Majority of Remaining Private Equity Portfolio

24 jul 2025, 06:09 UTC

Ganancias

3i Group 1Q Foreign Exchange Translation Gain GBP392M

24 jul 2025, 06:04 UTC

Ganancias

3i Group YTD Operating EBITDA GBP980M

3i Group PLC Esperado

Precio Objetivo

By TipRanks

37.11% repunte

Estimación a 12 meses

Media 4,330 GBX  37.11%

Máximo 5,200 GBX

Mínimo 3,150 GBX

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para 3i Group PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

8 ratings

6

Comprar

1

Mantener

1

Vender

Sentimiento

By Acuity

24 / 30 Clasificación en Índices

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de 3i Group PLC

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl
help-icon Live chat